[1]杜 森,赵 森,周 青,等.血清长链非编码RNA小核仁RNA宿主基因3检测联合核磁共振弥散加权成像在乳腺癌诊断中的应用[J].陕西医学杂志,2022,51(8):1021-1024,1037.[doi:DOI:10.3969/j.issn.1000-7377.2022.08.027]
　DU Sen,ZHAO Sen,ZHOU Qing,et al.Value of serum lncRNA SNHG3 detectioncombined with MRI diffusion-weighted imaging in diagnosis of breast cancer[J].,2022,51(8):1021-1024,1037.[doi:DOI:10.3969/j.issn.1000-7377.2022.08.027]
点击复制

血清长链非编码RNA小核仁RNA宿主基因3检测联合核磁共振弥散加权成像在乳腺癌诊断中的应用
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
51
期数:
2022年8期
页码:
1021-1024,1037
栏目:
临床检验
出版日期:
2022-08-05

文章信息/Info

Title:
Value of serum lncRNA SNHG3 detectioncombined with MRI diffusion-weighted imaging in diagnosis of breast cancer
作者:
杜 森; 赵 森; 周 青; 孙亮亮; 吴海滨
(河南大学第一附属医院,河南 开封 475100)
Author(s):
DU Sen; ZHAO Sen; ZHOU Qing; SUN Liangliang; WU Haibin
(The First Affiliated Hospital of Henan University,Kaifeng 475100,China)
关键词:
乳腺癌;  小核仁RNA宿主基因3;  核磁共振;  弥散加权成像;  表观扩散系数;  鉴别诊断
Keywords:
Breast cancer;  Small nucleolar RNA host gene 3;  Nuclear magnetic resonance;  Diffusion-weighted imaging;  Apparent diffusion coefficient;  Differential diagnosis
分类号:
R 737.9
DOI:
DOI:10.3969/j.issn.1000-7377.2022.08.027
文献标志码:
A
摘要:
目的:探究血清长链非编码RNA(lncRNA)小核仁RNA宿主基因3(SNHG3)水平检测联合磁共振弥散加权成像(DWI)对乳腺癌的诊断价值。方法:收集142例女性乳腺结节患者,分为乳腺癌组(n=88)和良性病变组(n=54)。所有入组患者均接受DWI检查。采用实时荧光定量PCR检测血清中lncRNA SNHG3表达水平。血清糖类抗原125(CA125)和癌胚抗原(CEA)用全自动化学发光免疫分析仪检测。采用Pearson法分析血清lncRNA SNHG3水平与CA125、CEA的相关性。采用受试者工作特征(ROC)曲线评价血清lncRNA SNHG3水平对乳腺癌的诊断效能。分析DWI联合血清lncRNA SNHG3对乳腺癌的诊断价值。结果:与良性病变组相比,乳腺癌组血清CA125、CEA、lncRNA SNHG3水平较高(均P<0.05),表观扩散系数(ADC)值较低(P<0.05)。Pearson分析显示,乳腺癌患者血清lncRNA SNHG3与CA125、CEA呈正相关(均P<0.05)。乳腺癌组病灶形状不规则比例、血管影增多比例、边界模糊比例、毛刺征比例及淋巴结肿大比例均高于良性病变组(均P<0.05)。血清lncRNA SNHG3联合ADC值诊断乳腺癌的准确度为88.03%,其敏感度、特异性分别为85.23%、92.59%。结论:lncRNA SNHG3在乳腺癌患者血清中表达上调,DWI联合血清lncRNA SNHG3水平对乳腺癌有较好的诊断价值。
Abstract:
Objective:To investigate the diagnostic value of serum long non-coding RNA(lncRNA)nucleolar small RNA host gene 3(SNHG3)level combined with magnetic resonance diffusion-weighted imaging(DWI)in the diagnosis of breast cancer.Methods:A total of 142 female breast nodules patients were collected and grouped into breast cancer group(88 cases)and benign lesion group(54 cases).All enrolled patients underwent DWI examination.The expression level of lncRNA SNHG3 in serum was detected by real-time fluorescence quantitative PCR.Serum carbohydrate antigen 125(CA125)and carcinoembryonic antigen(CEA)were detected by fully automatic chemiluminescence immunoassay.The correlation of serum lncRNA SNHG3 level with CA125 and CEA was analyzed by Pearson method.Receiver operating characteristic(ROC)curve was used to evaluate the diagnostic value of serum lncRNA SNHG3 level in breast cancer.The diagnostic value of DWI combined with serum lncRNA SNHG3 in breast cancer was analyzed.Results:Compared with the benign lesion group,the levels of serum CA125,CEA and lncRNA SNHG3 in the breast cancer group were higher,and the apparent diffusion coefficient(ADC)value was lower(all P<0.05).Pearson analysis showed that serum lncRNA SNHG3 was positively correlated with CA125 and CEA in breast cancer patients(all P<0.05).The proportions of lesions with irregular shape,increased vascular shadow,blurred boundary,burr sign and enlarged lymph nodes in the breast cancer group were higher than those in the benign lesion group(all P<0.05).The accuracy of serum lncRNA SNHG3 combined with ADC value in the diagnosis of breast cancer was 88.03%,and the sensitivity and specificity were 85.23% and 92.59%,respectively.Conclusion:The expression of lncRNA SNHG3 is up-regulated in the serum of breast cancer patients.DWI combined with serum lncRNA SNHG3 level has a good diagnostic value for breast cancer.

参考文献/References:

[1] 王群拴,黎小花.核磁共振结合血清肿瘤标志物及细胞因子检测在乳腺癌诊断中的应用价值研究[J].陕西医学杂志,2019,48(10):1295-1297.
[2] Feng RM,Zong YN,Cao SM,et al.Current cancer situation in China:Good or bad news from the 2018 global cancer statistics?[J].Cancer Commun(Lond),2019,39(1):22-34.
[3] Thompson JL,Wright GP.The role of breast MRI in newly diagnosed breast cancer:An evidence-based review?[J].Am J Surg,2021,221(3):525-528.
[4] 钱 丽,田为中,高 佳.MRI影像组学在乳腺癌中的研究进展[J].临床放射学杂志,2022,41(3):582-585.
[5] 蒋 超,郭 莉,邓 波.磁共振成像动态增强联合多b值弥散加权成像对乳腺癌的诊断价值[J].山西医药杂志,2020,49(17):2286-2287.
[6] 李 妍,马小平,刘 丹,等.LncRNA-SNHG3通过Hedgehog通路对乳腺癌细胞增殖的作用[J].医学研究杂志,2021,50(9):97-102.
[7] 程 辰,周胜利,周 军,等.磁共振动态增强联合弥散加权成像对乳腺癌的诊断价值研究[J].医学影像学杂志,2017,27(11):2122-2126.
[8] 唐 鹏,严玉钊,胡 滢,等.早发现早治疗乳腺癌5年生存率可达90%以上[J].中华医学信息导报,2021,36(8):9.
[9] 张栓宝,张燕平,严宁娟.康莱特注射液对乳腺癌新辅助化疗患者免疫功能、血管内皮生长因子及生活质量的影响[J].陕西中医,2019,40(11):1566-1569.
[10] 李长波,王斌杰,周 依.乳腺癌MRI表现与血清肿瘤标志物的相关性分析[J].中国CT和MRI杂志,2021,19(3):84-86.
[11] 赵 云,魏徐巍,魏小燕,等.钼靶X线联合磁共振加权成像在乳腺癌诊断中的价值[J].影像研究与医学应用,2021,23(5):23-25.
[12] 郑 超,苏 娟,盛杰鑫,等.乳腺癌患者病灶血流时间-信号强度曲线类型、表观弥散系数与化疗疗效相关性分析[J].陕西医学杂志,2021,50(12):1521-1524.
[13] 贾鹏欢,刘晓云.影像学新技术在宫颈癌淋巴结转移中的研究进展[J].贵州医药,2020,44(9):1366-1368.
[14] 林丽君,吕芳滨,谢森淼.动态增强磁共振成像联合磁共振弥散加权成像在宫颈癌患者分期诊断中的应用价值[J].中国妇幼保健,2021,36(21):5099-5101.
[15] 韩小双,高胜新.3.0T磁共振弥散加权成像联合动态增强在乳腺癌中的诊断价值[J].影像研究与医学应用,2021,5(17):84-85.
[16] 杜 欣,余建群,周 燚.核磁共振弥散加权成像联合血清肿瘤标志物检测在乳腺癌诊断中的应用[J].实用医院临床杂志,2020,17(3):98-101.
[17] 徐鸿斌.磁共振弥散加权成像联合血清血管内皮生长因子、基质金属蛋白酶抑制剂-1、基质金属蛋白酶-9检测对卵巢癌腹膜转移的诊断价值[J].中国性科学,2021,30(6):74-76.
[18] 张延涛,孙 勇,张远鹏.lncRNA SNHG12在乳腺癌中的表达水平及临床意义[J].河北医药,2020,42(1):62-65.
[19] Ma Q,Qi X,Lin X,et al.lncRNA SNHG3 promotes cell proliferation and invasion through the miR-384/hepatoma-derived growth factor axis in breast cancer[J].Hum Cell,2020,33(1):232-242.
[20] Zhao Q,Wu C,Wang J,et al.lncRNA SNHG3 promotes hepatocellular tumorigenesis by targeting miR-326[J].Tohoku J Exp Med,2019,249(1):43-56.
[21] Xu B,Mei J,Ji W,et al.lncRNA SNHG3,a potential oncogene in human cancers[J].Cancer Cell Int,2020,20(1):536-547.
[22] Wang P,Liu GZ,Wang JF,et al.SNHG3 silencing suppresses the malignant development of triple-negative breast cancer cells by regulating miRNA-326/integrin α 5 axis and inactivating Vav2/Rac1 signaling pathway[J].Eur Rev Med Pharmacol Sci,2020,24(10):5481-5492.
[23] Wang D,Zou L,Luo J,et al.Potential diagnostic and prognostic value of the long non-coding RNA SNHG3 in human cancers:A systematic review and meta-analysis[J].Int J Biol Markers,2022,37(1):3-12.
[24] Li X,Dai D,Chen B,et al.Prognostic values of preoperative serum CEA and CA125 levels and nomograms for young breast cancer patients[J].Onco Targets Ther,2019,12(1):8789-8800.

相似文献/References:

[1]乔亚舜,吴瑛琦.乳腔镜腋窝淋巴结清扫术治疗早期乳腺癌临床研究[J].陕西医学杂志,2019,(4):473.
　QIAO Yashun,WU Yingqi..Clinical study of mammoscopic axillary lymph node dissection for early breast cancer patients[J].,2019,(8):473.
[2]谭兴利,陆伟辉,汤学文,等.乳腺癌患者超声检查中PSV、RI值与术后组织中MMP11、VEGF表达的相关性探讨[J].陕西医学杂志,2019,(5):617.
[3]韩丕华,宋张骏△,杨晓民,等.乳腺超声造影联合细针穿刺定位活检在判定乳腺癌新辅助化疗后腋窝淋巴结性质中的临床研究*[J].陕西医学杂志,2019,(7):842.
　HAN Pihua,SONG Zhangjun,YANG Xiaomin,et al.Application of breast contrast-enhanced ultrasonography combined with fine needle aspiration biopsy in determining the axillary lymph node properties after neoadjuvant chemotherapy for breast cancer[J].,2019,(8):842.
[4]蒋 敢,王 军,王会东△.舒芬太尼联合罗哌卡因肋间神经阻滞对乳腺癌患者术后镇痛、免疫功能及应激反应的影响*[J].陕西医学杂志,2019,(8):1077.
　JIANG Gan,WANG Jun,WANG Huidong..Effect of sufentanil plus ropivacaine intercostal nerve block on postoperative analgesia, immunity and stress response in patients with breast cancer[J].,2019,(8):1077.
[5]王群拴,黎小花△.核磁共振结合血清肿瘤标志物及细胞因子检测在〖JZ〗乳腺癌诊断中的应用价值研究*[J].陕西医学杂志,2019,(10):1295.
[6]韩丕华,袁 权△.乳腺癌患者白细胞介素-22表达水平对新辅助化疗后病理学完全缓解的预测价值*[J].陕西医学杂志,2020,49(7):889.[doi:DOI:10.3969/j.issn.10007377.2020.07.033]
　HAN Pihua,YUAN Quan..Predictive value of IL-22 expression level in breast cancer patients for pathological complete remission after neoadjuvant chemotherapy[J].,2020,49(8):889.[doi:DOI:10.3969/j.issn.10007377.2020.07.033]
[7]韩金怡,苏志勇.21基因检测对早期Luminal A型乳腺癌治疗指导作用研究[J].陕西医学杂志,2021,50(9):1081.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.010]
　HAN Jinyi,SU Zhiyong.Guiding role of 21-gene detection in treatment of early Luminal type A breast cancer[J].,2021,50(8):1081.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.010]
[8]白玲娇,陈小军,王 婷.乳腺癌超声弹性成像评分与免疫组化指标表达水平相关性分析[J].陕西医学杂志,2021,50(10):1239.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.015]
[9]郑 超,苏 娟,盛杰鑫,等.乳腺癌患者病灶血流时间-信号强度曲线类型、表观弥散系数与化疗疗效相关性分析[J].陕西医学杂志,2021,50(12):1521.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.013]
　ZHENG Chao,SU Juan,SHENG Jiexin,et al.Correlation between focal blood flow time-signal intensity curve type,apparent diffusion coefficient and chemotherapy efficacy in breast cancer patients[J].,2021,50(8):1521.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.013]
[10]李福平,王 茂,邱春丽,等.莱菔硫烷联合维生素D对乳腺癌细胞增殖及凋亡的影响[J].陕西医学杂志,2022,51(8):916.[doi:DOI:10.3969/j.issn.1000-7377.2022.08.003]
　LI Fuping,WANG Mao,QIU Chunli,et al.Effect of sulforaphane combined with vitamin D on proliferation and apoptosis of breast cancer cells[J].,2022,51(8):916.[doi:DOI:10.3969/j.issn.1000-7377.2022.08.003]

备注/Memo

备注/Memo:
基金项目:河南省医学科技攻关计划项目(2018020311)
更新日期/Last Update: 2022-08-04